Gamma Investing LLC Biocryst Pharmaceuticals Inc Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Gamma Investing LLC holds 5,918 shares of BCRX stock, worth $41,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,918
Previous 469
1161.83%
Holding current value
$41,662
Previous $3.53 Million
77.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
280Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$140 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$83.5 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$64 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$57.3 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.31B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...